AP Biosciences Inc (TPEX:6945)
Taiwan · Delayed Price · Currency is TWD 141.00
+2.00 (1.44%)
At close: Dec 5, 2025
AP Biosciences Market Cap
AP Biosciences has a market cap or net worth of 12 billion as of December 5, 2025. Its market cap has increased by 175.10% in one year.
Market Cap
12.00B
Enterprise Value
10.71B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
141.00
Market Cap Chart
Since July 14, 2023, AP Biosciences's market cap has increased from 5.10B to 12.00B, an increase of 135.51%. That is a compound annual growth rate of 42.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 12.00B | 184.17% |
| Dec 31, 2024 | 4.22B | 39.97% |
| Dec 29, 2023 | 3.02B | -40.79% |
| Jul 14, 2023 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 258.22B |
| PharmaEssentia | 191.95B |
| Lotus Pharmaceutical | 78.89B |
| Bora Pharmaceuticals Co., LTD. | 65.31B |
| Oneness Biotech | 32.96B |
| Lumosa Therapeutics | 32.77B |
| Lin BioScience | 32.35B |
| Center Laboratories | 27.88B |